Euglycemic clamp study in clozapine-induced diabetic ketoacidosis

Annals of Pharmacotherapy

Volumn 35, Issue 11, 2001, Pages 1381-1387

  Avram, A M ^a   Patel, V ^a   Taylor, H C ^a   Kirwan, J P ^a   Kalhan, S ^a  

^a Lutheran Hospital Cleveland   (United States)

Author keywords

Clozapine; Diabetes mellitus; Euglycemic clamp; Ketoacidosis

Indexed keywords

AUTOANTIBODY; CLOZAPINE; GLUCOSE; GLUTAMATE DECARBOXYLASE; INSULIN; INSULIN ANTIBODY;

ADULT; ARTICLE; AUTOIMMUNITY; CASE REPORT; DIABETES MELLITUS; DIABETIC KETOACIDOSIS; DRUG WITHDRAWAL; GLUCOSE CLAMP TECHNIQUE; GLUCOSE METABOLISM; GLUCOSE TOLERANCE; HUMAN; INSULIN BLOOD LEVEL; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; INTRAVENOUS GLUCOSE TOLERANCE TEST; MALE; ORAL GLUCOSE TOLERANCE TEST; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL;

EID: 0034756893     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.10424     Document Type: Article

References (33)

1. New antipsychotic medications
2. Unique receptor-blockading profile of clozapine
3. Management of adverse effects of clozapine
4. Diabetic ketoacidosis associated with clozapine treatment
5. Ketoacidosis as a side effect of clozapine: A case report
6. Diabetic ketoacidosis from clozapine and lithium cotreatment
7. Clozapine and associated diabetes mellitus
8. Clozapine monotherapy and ketoacidosis
9. Diabetic ketoacidosis and clozapine
10. Novel antipsychotics and new onset diabetes
11. Clozapine-induced diabetic ketoacidosis
12. Diabetic ketoacidosis associated with clozapine treatment
13. Severe hyperglycemia associated with high doses of clozapine
14. Prevalence of diabetes and impaired glucose tolerance in patients treated with clozapine compared with patients treated with conventional depot neuroleptic medications
15. Quantitative estimation of insulin sensitivity
16. Eccentric exercise induces transient insulin resistance in healthy individuals
17. Glucose clamp technique: A method for quantifying insulin secretion and resistance
18. Calculation of substrate turnover rate in stable isotope tracer studies
19. Influences of glucose loading and of injected insulin on hepatic glucose output
20. Lilly lecture 1989. Toward physiological understanding of glucose tolerance. Minimal-model approach
21. First-degree relative of patients with type I diabetes: Islet-cell antibodies and abnormal insulin secretion
22. Abnormal circulating pancreatic enzyme activities in more than twenty-five percent of recent-onset insulin dependent diabetic patients: Association of hyperlipidemia with high-titer islet cell antibodies
23. A novel subtype of type 1 diabetes mellitus characterized by a rapid onset and an absence of diabetes-related antibodies
24. Clozapine, diabetes mellitus, weight gain and lipid abnormalities: A five-year naturalistic study
25. The effect of clozapine on glucose metabolism
26. Clozapine-induced weight gain: Prevalence and clinical relevance
27. Differential effect of clozapine on weight: A controlled study
28. Effects of clozapine on plasma cytokine and soluble cytokine receptor levels
29. The role of TNFα and TNF receptors in obesity and insulin resistance
30. 12 muscle cells
31. Insulin resistance versus insulin deficiency in non-insulin-dependent diabetes mellitus: Problems and prospects
32. Glucose toxicity
33. Chlorpromazine in the treatment of endogenous organic hyperinsulinism